FDA Experience With Regulation of Naloxone Products to Address the Opioid Crisis and Opportunities for Leveraging Scientific Engagement.
作者信息
Amur Shashi, Xu Yun, Hertz Sharon, Clingman Chekesha
机构信息
Science and Research Team, Office of Translational Sciences, Center for Drug Evaluation and Research, US, Food and Drug Administration, Silver Spring, Maryland, USA.
Division of Neuropsychiatric Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
出版信息
Clin Pharmacol Ther. 2021 Mar;109(3):569-572. doi: 10.1002/cpt.2086. Epub 2020 Nov 25.
DOI:10.1002/cpt.2086
PMID:33241562
Abstract
摘要
Zotero 插件